| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/27/2006 | WO2006043594A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006043064A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | WO2006042955A1 Pyridine derivatives and the preparation and the therapeutic use thereof |
| 04/27/2006 | WO2006042638A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/27/2006 | WO2006014290A3 Anti-inflammatory medicaments |
| 04/27/2006 | WO2006012256A3 Fkbp binding composition and pharmaceutical use thereof |
| 04/27/2006 | WO2006000371A3 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 04/27/2006 | WO2005101989A3 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 04/27/2006 | WO2005090320A3 Triazole derivatives and method of using the same to treat hiv infections |
| 04/27/2006 | US20060089386 Novel process for substituted sulfoxides |
| 04/27/2006 | US20060089383 Substituted piperidine compounds and methods of their use |
| 04/27/2006 | US20060089380 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584262A1 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583565A1 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease causedby necrosis or apoptosis |
| 04/27/2006 | CA2583534A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583392A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/27/2006 | CA2583342A1 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer's disease |
| 04/27/2006 | CA2583158A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | CA2583153A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | CA2582778A1 Pyridine derivatives and the preparation and the therapeutic use thereof |
| 04/26/2006 | EP1650204A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1649871A1 Retroviral protease inhibitor combinations |
| 04/26/2006 | EP1648884A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 04/26/2006 | EP1648883A2 Lanthanide complexes preparation and uses thereof |
| 04/26/2006 | EP1648882A1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 04/26/2006 | EP1648881A1 Substituted indole ligands for the orl-1 receptor |
| 04/26/2006 | EP1648879A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 04/26/2006 | EP1648878A1 Piperidine compounds and pharmaceutical compositions containing them |
| 04/26/2006 | EP1648877A1 Substituted pyridin-2-ylamine analogues |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | EP1648875A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 04/26/2006 | EP1648867A1 Ppar active compounds |
| 04/26/2006 | EP1648458A1 2-'4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamine derivtives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 04/26/2006 | EP1648448A1 Chemical compounds |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648443A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 04/26/2006 | EP1648426A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP0915844B1 Process for preparing 3-pyrroline-2-carboxylic acid derivatives |
| 04/26/2006 | CN1764668A Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 04/26/2006 | CN1764659A Prostaglandin analogs as EP4 receptor antagonists |
| 04/26/2006 | CN1764658A Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764649A Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 04/26/2006 | CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764450A Crystalline N-formyl hydroxylamine compounds |
| 04/26/2006 | CN1764380A N-phenyl- (4-pyridyl)- azinyl!amine derivatives as plant protection agents. |
| 04/26/2006 | CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034039 Fused heterocyclic compounds |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 04/25/2006 | US7034028 Treatment of inflammatory disorders |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 04/20/2006 | WO2006041635A2 Arylthiobenzylpiperidine derivatives |
| 04/20/2006 | WO2006041405A1 Substituted amino-pyrimidones and uses thereof |
| 04/20/2006 | WO2006040778A1 Process for preparations and purification of pantoprazole sesquihydrate |
| 04/20/2006 | WO2006040728A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 04/20/2006 | WO2006040666A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | WO2006040650A1 4-methoxyacridine-1-carboxamide derivatives and the phenazine and oxanthrene analogs as pde4-inhibitors for the treatment of asthma and chronic pulmonary disease (copd) |
| 04/20/2006 | WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1 |